What's new

Start of procedure: Type II variation - extension of indication under evaluation by the CHMP (28 February 2025 - 27 March 2025)

Start of procedure: Type II variation - extension of indication under evaluation by the CHMP (28 February 2025 - 27 March 2025)

Apr 1, 2025 - 11:12
 0
Start of procedure: Type II variation - extension of indication under evaluation by the CHMP (28 February 2025 - 27 March 2025)
Read More

Tags:

Previous Article

Start of procedure: Extension of marketing authorisation (28 February 2025 - 27 ...

Next Article

FTC Solar reports quarter-on-quarter revenue growth to US$13.2 million in Q4

Related Posts

PSUSA/00000434/202407

PSUSA/00000434/202407

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Efmody, hydrocortisone, Date of authorisation: 27/05/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025  0

Type-IA variations: questions and answers

Type-IA variations: questions and answers

Feb 19, 2025  0